Target (CBDY) Receivables - Other (2014 - 2026)

Target (CBDY) reported Receivables - Other of $3587.0 for Q1 2026, up 3.13% year-over-year from $3478.0 in Q1 2025, and little changed quarter-over-quarter from $3592.0 in Q3 2025.

Target (CBDY) Receivables - Other (2014 - 2026) Analysis & Trends

Target (CBDY) has 9 years of Receivables - Other data on file, last reported at $3587.0 in Q1 2026.

  • Receivables - Other for Q1 2026 came in at $3587.0, up 3.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $3587.0 (up 3.13% YoY), and the FY2024 annual result was $29334.0, up 675.83% from the prior year.
  • Receivables - Other held at $3587.0 in Q1 2026 per CBDY's latest filing, from $3592.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $29334.0 in Q4 2024 and troughed at $3478.0 in Q1 2025.
  • A 5-year average of $5304.2 and a median of $3692.5 in 2023 frame the typical range for Receivables - Other.
  • The sharpest annual moves came in 2023 and 2024: Receivables - Other declined 7.67% in 2023, then surged 675.83% in 2024.
  • A 5-year view of Receivables - Other shows it stood at $3683.5 in 2022, then gained by 2.65% to $3781.0 in 2023, then surged by 675.83% to $29334.0 in 2024, then plunged by 87.75% to $3592.0 in 2025, then dropped by 0.14% to $3587.0 in 2026.
  • Business Quant data shows CBDY's Receivables - Other at $3587.0 in Q1 2026, $3592.0 in Q3 2025, and $3665.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Target - - 191,787.00

Historic Data

Download Data
DateValue
Mar 31, 2026 3,587.00
Mar 31, 2026 3,587.00
Sep 30, 2025 3,592.00
Sep 30, 2025 3,592.00
Jun 30, 2025 3,665.00
Jun 30, 2025 3,665.00
Mar 31, 2025 3,478.00
Mar 31, 2025 3,478.00
Dec 31, 2024 29,334.00
Dec 31, 2024 29,334.00
Sep 30, 2024 3,704.00
Sep 30, 2024 3,704.00
Jun 30, 2024 3,653.00
Jun 30, 2024 3,653.00
Mar 31, 2024 3,690.00
Mar 31, 2024 3,690.00
Dec 31, 2023 3,781.00
Dec 31, 2023 3,781.00
Sep 30, 2023 3,698.00
Sep 30, 2023 3,698.00